Table 3.
Hazard ratio | 95 % confidence Interval | p value | |
---|---|---|---|
ESA category (U/kg/week)a | |||
1. No ESA | 2.71 | 0.81–9.00 | 0.39 |
2. EPO: 0 to <100/DARBO: 0 to <0.49 | 1.62 | 0.54–4.90 | 0.10 |
3. EPO: 200 to <350/DARBO 1 to <1.5 | 1.81 | 0.67–4.87 | 0.24 |
4. EPO ≥350/DARBO ≥1.5 | 3.37 | 1.37–8.26 | 0.01 |
Race | |||
Black vs white | 1.36 | 0.77–2.41 | 0.29 |
Other vs white | 0.98 | 0.42–2.28 | 0.97 |
Diagnosis | |||
Urological vs other | 0.42 | 0.21–0.81 | 0.01 |
SLE vs other | 0.43 | 0.97–1.90 | 0.27 |
FSGS vs other | 0.57 | 0.23–1.38 | 0.21 |
Hemoglobin≥11 g/dL (yes vs no) | 0.79 | 0.47–1.33 | 0.37 |
Albumin≥3.5 g/dL BCG/3.2 g/dL BCP (yes vs no) | 0.66 | 0.38–1.14 | 0.13 |
Dialysis modality | |||
HD AVG/AVF vs PD | 0.47 | 0.17–1.27 | 0.14 |
HD with catheter vs PD | 2.14 | 1.19–3.86 | 0.01 |
Age (per 1 year increase) | 0.91 | 0.86–0.96 | 0.001 |
Male vs female | 1.3 | 0.76–2.23 | 0.34 |
Kt/V ≥1.2 (HD)/1.8 (PD) vs <1.2/1.8 | 0.63 | 0.32–1.23 | 0.01 |
Time on dialysis ≥1 year vs <1 year | 1.26 | 0.73–2.19 | 0.40 |
ESA dose category EPO 100 to <200/DARBO 0.49 to 1.0 U/kg/week reference